Investment
Features
FeesSafety
Academy
More
Pluang+

Compare EOG Resources Inc (EOG) vs Heron Therapeutics Inc (HRTX) Price & Performance

EOG Resources IncTrade
Heron Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

EOG Resources Inc vs Heron Therapeutics Inc — how do they compare? EOG Resources Inc trades at $138.44 (market cap $73.22B), while Heron Therapeutics Inc trades at $0.48 (market cap $84.50M). The key difference: EOG Resources Inc is far larger — about 866.5× Heron Therapeutics Inc's market cap, and EOG Resources Inc pays a 2.97% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.

EOGHRTX
Market Cap
$73.22B$84.50M
Sector
EnergyHealth
52-Week High
$149.89$2.02
52-Week Low
$101.78$0.39
Enterprise Value
$77.68B$182.40M
Dividend Yield
2.97%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

EOG Resources Inc

EOG Resources trades at $139.12, up 0.8% on the day, with a bullish technical outlook supported by moving averages and key resistance at $140. The company maintains strong profitability with a 23.39% net income margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights EOG's valuation discount and operational strength, with a consensus price target of $156.40 suggesting 12% upside.

EOG presents a compelling investment case with solid fundamentals, consistent earnings beats, and positive analyst sentiment, though risks include oil price volatility and elevated capital expenditures. The stock's current valuation below historical averages offers a margin of safety for long-term investors seeking exposure to a high-quality energy producer.

Heron Therapeutics Inc

HRTX trades at $0.44, up 2.63% today, with a bullish technical signal but bearish moving averages. The company reported Q1 2026 revenue of $151M with a net loss of $31M, maintaining a negative profit margin of -20.53%. Recent patent litigation developments and mixed earnings performance create uncertainty, though analyst consensus remains overwhelmingly positive with 94.7% buy ratings.

The outlook remains challenging with persistent losses and negative cash flow from operations, though improving net cash flow trends offer some optimism. Key risks include ongoing patent litigation and execution challenges in achieving profitability. The strong analyst support suggests potential upside if the company can deliver on its guidance and improve operational efficiency.

Returns comparison

Trailing returns across standard periods

About EOG Resources Inc

EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.

Read more on EOG

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX